Discovery, whose share price has been knocked by the advancement of the controversial National Health Insurance (NHI) Bill, says while the legislation's restriction of SA's medical schemes would be counterproductive, it would not be a death knell for the industry.

Discovery’s valuation has declined by almost a third over the past two months, partly on concerns about what the NHI will mean for private healthcare operators once fully implemented...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now